Topical diphenylcyclopropenone
Selected Abstract
Topical diphenylcyclopropenone as a measure of immune competence in HIV-seropositive subjects.
Abstract Background: CD4 T cell counts are recognized as the standard method for monitoring HIV-seropositive patients and, along with viral load, are clinically important as indicators for initiating highly active antiretrovival therapy (HAART). Skin reaction scores following topical application of ... October 1, 2006; Journal of Drugs in Dermatology
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Topical diphenylcyclopropenone as a measure of immune competence in HIV-seropositive subjects.
|
